On Thursday, September 15, 2022, Deputy Attorney General Lisa A. Monaco outlined new steps the Department of Justice will be taking in its ongoing efforts to police corporate crime. The next day, Assistant Attorney General...more
9/23/2022
/ Compliance ,
Corporate Crimes ,
Corporate Criminal Fines ,
Corporate Misconduct ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Enforcement ,
Government Investigations ,
New Guidance ,
Voluntary Disclosure ,
White Collar Crimes
This month, the Department of Justice (DOJ)—as a product of the Criminal Division’s continued efforts to combat healthcare fraud—announced criminal charges against over 100 defendants, including 42 doctors, nurses, and other...more
The national opioid epidemic is almost unprecedented in every conceivable way—its catastrophic death toll, its broad effect on a wide swath of this country’s population, its rapid escalation (which is alleged to have been...more
5/8/2019
/ Anti-Kickback Statute ,
CEOs ,
Chief Compliance Officers ,
Controlled Substances ,
Corporate Executives ,
Corporate Liability ,
Corporate Misconduct ,
Criminal Investigations ,
Criminal Liability ,
Criminal Prosecution ,
DEA ,
Deferred Prosecution Agreements ,
Enforcement Actions ,
Failure to Report ,
Health Care Providers ,
Indictments ,
Opioid ,
Pharmaceutical Industry ,
Pharmacies ,
Physicians ,
Prescription Drugs ,
White Collar Crimes